150 related articles for article (PubMed ID: 23299527)
1. In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
Kretschy N; Teichmann M; Kopf S; Atanasov AG; Saiko P; Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Krieger S; Jäger W; Szekeres T; Nijman SM; Mikulits W; Dirsch VM; Dolznig H; Grusch M; Krupitza G
Br J Cancer; 2013 Feb; 108(3):570-8. PubMed ID: 23299527
[TBL] [Abstract][Full Text] [Related]
2. Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion.
Viola K; Kopf S; Huttary N; Vonach C; Kretschy N; Teichmann M; Giessrigl B; Raab I; Stary S; Krieger S; Keller T; Bauer S; Hantusch B; Szekeres T; de Martin R; Jäger W; Mikulits W; Dolznig H; Krupitza G; Grusch M
Br J Cancer; 2013 Feb; 108(3):564-9. PubMed ID: 23093227
[TBL] [Abstract][Full Text] [Related]
3. NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells.
Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Kalt R; Krieger S; Vo TP; Madlener S; Bauer S; Marian B; Hämmerle M; Kretschy N; Teichmann M; Hantusch B; Stary S; Unger C; Seelinger M; Eger A; Mader R; Jäger W; Schmidt W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Br J Cancer; 2011 Jul; 105(2):263-71. PubMed ID: 21629247
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis.
Viola K; Kopf S; Rarova L; Jarukamjorn K; Kretschy N; Teichmann M; Vonach C; Atanasov AG; Giessrigl B; Huttary N; Raab I; Krieger S; Strnad M; de Martin R; Saiko P; Szekeres T; Knasmüller S; Dirsch VM; Jäger W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Arch Toxicol; 2013 Jul; 87(7):1301-12. PubMed ID: 23503627
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model.
Teichmann M; Kretschy N; Kopf S; Jarukamjorn K; Atanasov AG; Viola K; Giessrigl B; Saiko P; Szekeres T; Mikulits W; Dirsch VM; Huttary N; Krieger S; Jäger W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2014 Mar; 88(3):691-9. PubMed ID: 24352538
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
Kopf S; Viola K; Atanasov AG; Jarukamjorn K; Rarova L; Kretschy N; Teichmann M; Vonach C; Saiko P; Giessrigl B; Huttary N; Raab I; Krieger S; Schumacher M; Diederich M; Strnad M; de Martin R; Szekeres T; Jäger W; Dirsch VM; Mikulits W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2013 Oct; 87(10):1851-61. PubMed ID: 23543012
[TBL] [Abstract][Full Text] [Related]
7. 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply.
Nguyen CH; Brenner S; Huttary N; Li Y; Atanasov AG; Dirsch VM; Holzner S; Stadler S; Riha J; Krieger S; Milovanovic D; Fristiohardy A; Simonitsch-Klupp I; Dolznig H; Saiko P; Szekeres T; Giessrigl B; Jäger W; Krupitza G
Cancer Lett; 2016 Sep; 380(1):174-83. PubMed ID: 27390016
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
Nguyen CH; Huttary N; Atanasov AG; Chatuphonprasert W; Brenner S; Fristiohady A; Hong J; Stadler S; Holzner S; Milovanovic D; Dirsch VM; Kopp B; Saiko P; Krenn L; Jäger W; Krupitza G
Int J Oncol; 2017 May; 50(5):1879-1888. PubMed ID: 28393180
[TBL] [Abstract][Full Text] [Related]
9. Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
Kiss I; Unger C; Huu CN; Atanasov AG; Kramer N; Chatruphonprasert W; Brenner S; McKinnon R; Peschel A; Vasas A; Lajter I; Kain R; Saiko P; Szekeres T; Kenner L; Hassler MR; Diaz R; Frisch R; Dirsch VM; Jäger W; de Martin R; Bochkov VN; Passreiter CM; Peter-Vörösmarty B; Mader RM; Grusch M; Dolznig H; Kopp B; Zupko I; Hohmann J; Krupitza G
Cancer Lett; 2015 Jan; 356(2 Pt B):994-1006. PubMed ID: 25444930
[TBL] [Abstract][Full Text] [Related]
10. AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis.
Nguyen CH; Brenner S; Huttary N; Atanasov AG; Dirsch VM; Chatuphonprasert W; Holzner S; Stadler S; Riha J; Krieger S; de Martin R; Bago-Horvath Z; Krupitza G; Jäger W
Hum Mol Genet; 2016 Nov; 25(22):5006-5016. PubMed ID: 28171546
[TBL] [Abstract][Full Text] [Related]
11. NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.
Nguyen CH; Senfter D; Basilio J; Holzner S; Stadler S; Krieger S; Huttary N; Milovanovic D; Viola K; Simonitsch-Klupp I; Jäger W; de Martin R; Krupitza G
Oncotarget; 2015 Nov; 6(36):39262-75. PubMed ID: 26513020
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching.
Nguyen CH; Stadler S; Brenner S; Huttary N; Krieger S; Jäger W; Dolznig H; Krupitza G
Br J Cancer; 2016 Jul; 115(3):364-70. PubMed ID: 27362730
[TBL] [Abstract][Full Text] [Related]
13. Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.
Holzner S; Brenner S; Atanasov AG; Senfter D; Stadler S; Nguyen CH; Fristiohady A; Milovanovic D; Huttary N; Krieger S; Bago-Horvath Z; de Wever O; Tentes I; Özmen A; Jäger W; Dolznig H; Dirsch VM; Mader RM; Krenn L; Krupitza G
Food Chem Toxicol; 2018 Jan; 111():114-124. PubMed ID: 29129665
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.
Holzner S; Senfter D; Stadler S; Staribacher A; Nguyen CH; Gaggl A; Geleff S; Huttary N; Krieger S; Jäger W; Dolznig H; Mader RM; Krupitza G
Oncol Rep; 2016 Nov; 36(5):3065-3071. PubMed ID: 27666412
[TBL] [Abstract][Full Text] [Related]
15. Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro.
Senfter D; Holzner S; Kalipciyan M; Staribacher A; Walzl A; Huttary N; Krieger S; Brenner S; Jäger W; Krupitza G; Dolznig H; Mader RM
Hum Mol Genet; 2015 Jul; 24(13):3689-98. PubMed ID: 25832648
[TBL] [Abstract][Full Text] [Related]
16. Effects of Scrophularia extracts on tumor cell proliferation, death and intravasation through lymphoendothelial cell barriers.
Giessrigl B; Yazici G; Teichmann M; Kopf S; Ghassemi S; Atanasov AG; Dirsch VM; Grusch M; Jäger W; Ozmen A; Krupitza G
Int J Oncol; 2012 Jun; 40(6):2063-74. PubMed ID: 22367166
[TBL] [Abstract][Full Text] [Related]
17. Feed‑back loops integrating RELA, SOX18 and FAK mediate the break‑down of the lymph‑endothelial barrier that is triggered by 12(S)‑HETE.
Engleitner S; Milovanovic D; Kirisits K; Brenner S; Hong J; Ropek N; Huttary N; Rehak J; Nguyen CH; Bago-Horvath Z; Knasmüller S; De Martin R; Jäger W; Krupitza G
Int J Oncol; 2020 Apr; 56(4):1034-1044. PubMed ID: 32319559
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
19. Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.
Yan M; Xu Q; Zhang P; Zhou XJ; Zhang ZY; Chen WT
BMC Cancer; 2010 Aug; 10():437. PubMed ID: 20716363
[TBL] [Abstract][Full Text] [Related]
20. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.
Nakayama H; Ohuchida K; Yonenaga A; Sagara A; Ando Y; Kibe S; Takesue S; Abe T; Endo S; Koikawa K; Okumura T; Shido K; Miyoshi K; Nakata K; Moriyama T; Miyasaka Y; Inoue S; Ohtsuka T; Mizumoto K; Nakamura M
Int J Oncol; 2019 Jul; 55(1):211-222. PubMed ID: 31180531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
